Surface modification with PEG and hirudin for protein resistance and thrombin neutralization in blood contact
- PMID: 20709502
- DOI: 10.1016/j.colsurfb.2010.07.024
Surface modification with PEG and hirudin for protein resistance and thrombin neutralization in blood contact
Abstract
In this work, we hypothesize that a surface modified with both polyethylene glycol (PEG) and hirudin may provide a non-fouling, thrombin-neutralizing surface suitable for blood contacting applications. With gold as a model substrate we used two different approaches to the preparation of such a surface: (1) a "direct" method in which PEG was conjugated to hirudin and the conjugate was then immobilized on the gold; (2) a "sequential" method in which PEG was immobilized on the gold and hirudin then attached to the immobilized PEG. The surfaces were characterized by water contact angle, ellipsometry and XPS. The biological properties were investigated by measuring protein adsorption (fibrinogen and thrombin) from buffer and plasma; thrombin inhibition was measured using a chromogenic substrate assay. Hirudin immobilization was found to be more efficient on surfaces prepared by the "direct" method. "Sequential" surfaces, however, despite having a lower density of hirudin, showed greater biological activity (thrombin binding and inhibition).
Copyright © 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Surface modification with polyethylene glycol-corn trypsin inhibitor conjugate to inhibit the contact factor pathway on blood-contacting surfaces.Acta Biomater. 2011 Dec;7(12):4177-86. doi: 10.1016/j.actbio.2011.07.022. Epub 2011 Jul 30. Acta Biomater. 2011. PMID: 21827874
-
The effect of immobilization of thrombin inhibitors onto self-assembled monolayers on the adsorption and activity of thrombin.Biomaterials. 2010 May;31(14):3772-80. doi: 10.1016/j.biomaterials.2010.01.097. Epub 2010 Feb 11. Biomaterials. 2010. PMID: 20153046
-
Immobilization of heparin on a silicone surface through a heterobifunctional PEG spacer.Biomaterials. 2005 Dec;26(35):7418-24. doi: 10.1016/j.biomaterials.2005.05.053. Biomaterials. 2005. PMID: 16051347
-
Structure-activity relationships of recombinant hirudins.Semin Thromb Hemost. 1991 Apr;17(2):94-8. doi: 10.1055/s-2007-1002595. Semin Thromb Hemost. 1991. PMID: 1771418 Review.
-
Thrombin inhibition by hirudin: how hirudin inhibits thrombin.Haemostasis. 1991;21 Suppl 1:27-31. doi: 10.1159/000216259. Haemostasis. 1991. PMID: 1894193 Review.
Cited by
-
Control of Blood Coagulation by Hemocompatible Material Surfaces-A Review.Bioengineering (Basel). 2021 Dec 15;8(12):215. doi: 10.3390/bioengineering8120215. Bioengineering (Basel). 2021. PMID: 34940368 Free PMC article. Review.
-
Unravelling Surface Modification Strategies for Preventing Medical Device-Induced Thrombosis.Adv Healthc Mater. 2024 Jan;13(1):e2301039. doi: 10.1002/adhm.202301039. Epub 2023 Oct 5. Adv Healthc Mater. 2024. PMID: 37725037 Free PMC article. Review.
-
Surface Texturing and Combinatorial Approaches to Improve Biocompatibility of Implanted Biomaterials.Front Phys. 2022;10:994438. doi: 10.3389/fphy.2022.994438. Epub 2022 Nov 16. Front Phys. 2022. PMID: 38250242 Free PMC article.
-
Combination strategies for antithrombotic biomaterials: an emerging trend towards hemocompatibility.Biomater Sci. 2021 Apr 7;9(7):2413-2423. doi: 10.1039/d0bm02154g. Epub 2021 Feb 18. Biomater Sci. 2021. PMID: 33599226 Free PMC article.
-
The blood compatibility challenge. Part 2: Protein adsorption phenomena governing blood reactivity.Acta Biomater. 2019 Aug;94:11-24. doi: 10.1016/j.actbio.2019.06.022. Epub 2019 Jun 18. Acta Biomater. 2019. PMID: 31226477 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources